SYK Stryker Corporation

P/E 31.54
Forward P/E 16.47
Price/Sales 4.519
Beta 0.781
Div Yield 0.0117%
Market Cap --

Company Analysis

Latest News

🟢 Stryker is trading 4.02% up on October 15, 2026, amid a broad healthcare rally

Stryker is trading at $292.95, up +4.02%, amid a broad healthcare rally. - The sector ETF is up 2.12%, supported by strong earnings from UnitedHealth and...

Stryker Announces CEO Transition; President Spencer Stiles Appointed Successor

Stryker announced a planned leadership succession in which current Chief Executive Officer, Kevin A. Lobo, will resign from his role and transition to...

Stryker Faces Probe Over Vascular Manufacturing Disclosures After Shares Slide

Shareholders’ rights law firm Hagens Berman has opened an investigation into whether Stryker Corporation adequately disclosed a persistent manufacturing issue...

🟢 Stryker is trading 23% up in pre-market with no credible overnight catalyst identified

Stryker is trading 22.82% up at $336.77 after rising sharply from the September 21 close of $274.19; no credible overnight catalyst has been identified. -...

AKO Capital Reduces Stryker Stake by Over 90%

London-based investment firm AKO Capital significantly decreased its position in medical technology company Stryker Corporation (SYK) during the second quarter...

Stryker's second quarter revenue rose to $6.6B with 9.0% organic growth, signaling a strong post-cyberattack recovery.

Stryker reported second quarter 2026 revenue of $6.6 billion, up 9.4% year-over-year, and reported EPS of $3.30. Adjusted EPS of $3.69 increased 17.9% and...

Stryker Corporation Q2 2026 Earnings Preview: What Analysts Expect on July 30, 2026

Stryker is expected to report Q2 2026 revenue of $6.56 billion and earnings of $3.46 per share, with the stock currently trading at $345.08 against an average...

FBI and US Infrastructure Breached by Foreign Hackers, Exposing Sensitive Data

State-sponsored cyberattacks targeted U.S. critical infrastructure and federal agencies during the first half of 2026. Iran-affiliated groups disrupted...

Stryker's first quarter 2026 adjusted EPS fell 8.5% on slow growth, but the company reaffirms full-year guidance.

Stryker reported first quarter 2026 net sales of $6.02 billion, a 2.6% increase year-over-year, while adjusted EPS decreased 8.5% to $2.60. Organic sales...

Stryker Corporation Q1 2026 Earnings Preview: What Analysts Expect on April 30, 2026

Stryker is expected to report Q1 2026 revenue of $6.36 billion and EPS of $2.99, with its current price of $327.51 trading significantly below the $421.00...

Stryker Global Operations Paralyzed as Pro-Iran Hackers Deploy Destructive Wiper Malware

Stryker Global Operations Paralyzed as Pro-Iran Hackers Deploy Destructive Wiper Malware

Medical technology giant Stryker is facing a worldwide system outage following a major cyberattack on March 11, 2026. The disruption wiped data from company...